CBLL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ceribell Inc. is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The business is growing well, but the stock does not have a clear technical breakout, there is no fresh news catalyst, and the proprietary signals do not show an active buy setup today. If the investor is impatient and wants to act now, the better call is to hold off rather than force an entry.
CBLL is trading near flat at 20.36 versus the prior close of 20.38, so momentum is neutral. RSI_6 at 51.0 is neutral, MACD histogram is slightly negative at -0.0938 and still contracting, and moving averages are converging, which points to a sideways setup rather than a confirmed uptrend. The pivot is 20.347, with resistance at 21.325 and 21.929 and support at 19.369 and 18.765. Overall, price action looks balanced with no clear technical edge for an immediate buy.
Revenue in Q4 2025 grew 33.72% YoY, showing strong top-line expansion. Analyst sentiment remains positive with Canaccord keeping a Buy rating and even after trimming the target to $28 from $30, the target still implies meaningful upside from the current price. Earnings are scheduled soon on 2026-05-11 after hours, and the company has been described as having multiple drivers upcoming. There is also a mild supportive options skew from the put-call ratio.
No news was reported in the recent week, so there is no fresh event-driven catalyst. Insider and hedge fund trading trends are both neutral, and there is no recent congress trading activity. Net income remains negative at -13.53M and EPS is still negative at -0.36, so the company is still not profitable. Gross margin also slipped slightly, and the stock is not currently showing a strong technical or proprietary signal.
In Q4 2025, Ceribell posted revenue of 24.784M, up 33.72% year over year, which is a strong growth rate. Net income improved only modestly, remaining negative at -13.527M, and EPS was -0.36, also still negative but slightly better year over year. Gross margin was very strong at 87.33%, though it edged down slightly. Overall, the latest quarter shows strong growth but continued losses, which is better for a growth story than for a conservative long-term buy.
Canaccord lowered its price target to $28 from $30 on 2026-02-25 while keeping a Buy rating. That is still a bullish stance overall, and the note said the company delivered a solid Q4 beat and gave conservative guidance with multiple upcoming drivers. Wall Street pros appear constructive on the long-term story, but the reduced target suggests slightly less near-term enthusiasm than before.
